Search

everythinglearnresearchcommunity

for

Search:↓

EDA and EDAR are important for hair follicle development in cashmere goats and affect other related genes.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

Systemic retinoids may effectively treat erosive pustular dermatosis of the scalp.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Understanding genetics is crucial for treating heart and skin diseases.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

MSUD patients need careful monitoring of amino acids and zinc to prevent severe symptoms.

Timely treatment of EPDS can reduce scarring.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Chronic scalp lesions with crusts and pus that heal with strong topical steroids suggest Erosive Pustular Dermatosis, confirmed by biopsy showing specific immune cells.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Accurate diagnosis of RDEB-mitis in older adults is crucial for proper management without immunosuppressants.

Deep Brain Stimulation helps manage Parkinson's symptoms when medication isn't enough.

Researchers found a new mutation in the EDA gene that likely causes missing teeth and mild skin symptoms in one family.

Chronic scalp lesions with crusts and pus indicate Erosive Pustular Dermatosis, which is confirmed by biopsy and effectively treated with strong topical steroids.

The horse had a rare disease causing weight loss and skin issues, leading to euthanasia due to poor treatment options.

A rare scalp condition was successfully treated with specific medications after 9 months.

Some patients who had a severe drug reaction developed long-term hair loss.

The document corrected previous errors and announced future dermatology events.

Individualized treatments may help manage Dercum's disease symptoms.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

The document concludes that detailed clinical descriptions of seven family cases help understand dominant dystrophic epidermolysis bullosa's symptoms and inheritance.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

EPDS and MS might share an immune-related cause.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

Stem cell niches are crucial for regulating stem cell behavior and tissue health, and their decline can impact aging and cancer.

Microtechnology methods improve organoid production for medical research.